Chromosome 2

Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ENTITIES: by Chromosome band

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Chromosome 2


[previous]   2 2p 2q 2p25 2p24 2p23 2p22 2p21 2p16 2p15 2p14 2p13 2p12 2p11 2q11 2q12 2q13 2q14 2q21 2q22 2q23 2q24 2q31 2q32 2q33 2q34 2q35 2q36 2q37   [next]

chr2:0-242193529 (242193.529 Kb)

Abnormalities in chromosome 2

(click on headers to reorder columns)
Band 1Band 2ClassEntityPartner 1Partner 2LinksTopographyMorphology[PubMed][Study]
  Mitelman-2  Mitelman (ISB-CGC) Acute erythroleukemia (FAB type M6)  
  Mitelman+2  Mitelman (ISB-CGC) Acute erythroleukemia (FAB type M6)  
  Mitelman-2  Mitelman (ISB-CGC) Acute lymphoblastic leukemia/lymphoblastic lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Acute lymphoblastic leukemia/lymphoblastic lymphoma  
  Mitelman-2  Mitelman (ISB-CGC) Acute megakaryoblastic leukemia (FAB type M7)  
  Mitelman+2  Mitelman (ISB-CGC) Acute megakaryoblastic leukemia (FAB type M7)  
  Mitelman-2  Mitelman (ISB-CGC) Acute monoblastic leukemia (FAB type M5)  
  Mitelman+2  Mitelman (ISB-CGC) Acute monoblastic leukemia (FAB type M5)  
  Mitelman+2  Mitelman (ISB-CGC) Acute monoblastic leukemia with differentiation (FAB type M5b)  
  Mitelman-2  Mitelman (ISB-CGC) Acute monoblastic leukemia without differentiation (FAB type M5a)  
  Mitelman+2  Mitelman (ISB-CGC) Acute monoblastic leukemia without differentiation (FAB type M5a)  
  Mitelman-2  Mitelman (ISB-CGC) Acute myeloblastic leukemia with maturation (FAB type M2)  
  Mitelman+2  Mitelman (ISB-CGC) Acute myeloblastic leukemia with maturation (FAB type M2)  
  Mitelman-2  Mitelman (ISB-CGC) Acute myeloblastic leukemia with minimal differentiation (FAB type M0)  
  Mitelman+2  Mitelman (ISB-CGC) Acute myeloblastic leukemia with minimal differentiation (FAB type M0)  
  Mitelman-2  Mitelman (ISB-CGC) Acute myeloblastic leukemia without maturation (FAB type M1)  
  Mitelman+2  Mitelman (ISB-CGC) Acute myeloblastic leukemia without maturation (FAB type M1)  
  Mitelman-2  Mitelman (ISB-CGC) Acute myeloid leukemia, NOS  
  Mitelman+2  Mitelman (ISB-CGC) Acute myeloid leukemia, NOS  
  Mitelman-2  Mitelman (ISB-CGC) Acute myeloid leukemia, special type  
  Mitelman-2  Mitelman (ISB-CGC) Acute myelomonocytic leukemia (FAB type M4)  
  Mitelman+2  Mitelman (ISB-CGC) Acute myelomonocytic leukemia (FAB type M4)  
  Mitelman-2  Mitelman (ISB-CGC) Acute promyelocytic leukemia (FAB type M3)  
  Mitelman+2  Mitelman (ISB-CGC) Adenocarcinoma  
  Mitelman-2  Mitelman (ISB-CGC)AdrenalNeuroblastoma  
  Mitelman+2  Mitelman (ISB-CGC)AdrenalNeuroblastoma  
  Mitelman-2  Mitelman (ISB-CGC) Adult T-cell lymphoma/leukemia (HTLV-1+)  
  Mitelman+2  Mitelman (ISB-CGC) Adult T-cell lymphoma/leukemia (HTLV-1+)  
  Mitelman+2  Mitelman (ISB-CGC) Anaplastic large cell lymphoma, cutaneous type  
  Mitelman-2  Mitelman (ISB-CGC) Anaplastic large cell lymphoma, systemic type  
  Mitelman+2  Mitelman (ISB-CGC) Anaplastic large cell lymphoma, systemic type  
  Mitelman+2  Mitelman (ISB-CGC) Angioimmunoblastic T-cell lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) B-cell lymphoma associated with hemophagocytic syndrome  
  Mitelman-2  Mitelman (ISB-CGC) Bilineage or biphenotypic leukemia  
  Mitelman+2  Mitelman (ISB-CGC) Bilineage or biphenotypic leukemia  
  Mitelman+2  Mitelman (ISB-CGC)BladderEmbryonal rhabdomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)BladderTransitional cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)BladderTransitional cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC) B-prolymphocytic leukemia  
  Mitelman-2  Mitelman (ISB-CGC)BrainAstrocytoma, grade III-IV/Glioblastoma  
  Mitelman+2  Mitelman (ISB-CGC)BrainAstrocytoma, grade III-IV/Glioblastoma  
  Mitelman-2  Mitelman (ISB-CGC)BrainAstrocytoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)BrainAstrocytoma, NOS  
  Mitelman-2  Mitelman (ISB-CGC)BrainChoroid plexus papilloma/carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)BrainChoroid plexus papilloma/carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)BrainEpendymoma  
  Mitelman-2  Mitelman (ISB-CGC)BrainGlioma, NOS  
  Mitelman-2  Mitelman (ISB-CGC)BrainMeningioma  
  Mitelman+2  Mitelman (ISB-CGC)BrainMeningioma  
  Mitelman-2  Mitelman (ISB-CGC)BrainNeuroglial neoplasm, special type  
  Mitelman+2  Mitelman (ISB-CGC)BrainNeuroglial neoplasm, special type  
  Mitelman+2  Mitelman (ISB-CGC)BrainPrimitive neuroectodermal tumor/Medulloblastoma  
  Mitelman+2  Mitelman (ISB-CGC)Brain stemAstrocytoma, grade III-IV/Glioblastoma  
  Mitelman+2  Mitelman (ISB-CGC)Brain stemGlioma, NOS  
  Mitelman-2  Mitelman (ISB-CGC)BreastAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)BreastAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)BreastBenign epithelial tumor, NOS  
  Mitelman-2  Mitelman (ISB-CGC)BreastCarcinoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)BreastCarcinoma, NOS  
  Mitelman-2  Mitelman (ISB-CGC)BreastNonneoplastic epithelial disorder/lesion  
  Mitelman+2  Mitelman (ISB-CGC)BreastPhyllodes tumor, malignant  
  Mitelman-2  Mitelman (ISB-CGC) Burkitt lymphoma/leukemia  
  Mitelman+2  Mitelman (ISB-CGC) Burkitt lymphoma/leukemia  
  Mitelman+2  Mitelman (ISB-CGC)CerebellumEpendymoma  
  Mitelman-2  Mitelman (ISB-CGC)CerebellumPrimitive neuroectodermal tumor/Medulloblastoma  
  Mitelman+2  Mitelman (ISB-CGC)CerebellumPrimitive neuroectodermal tumor/Medulloblastoma  
  Mitelman-2  Mitelman (ISB-CGC) Chronic lymphocytic leukemia  
  Mitelman+2  Mitelman (ISB-CGC) Chronic lymphocytic leukemia  
  Mitelman+2  Mitelman (ISB-CGC) Chronic myeloid leukemia, aberrant translocation  
  Mitelman-2  Mitelman (ISB-CGC) Chronic myeloid leukemia, t(9;22)  
  Mitelman+2  Mitelman (ISB-CGC) Chronic myeloid leukemia, t(9;22)  
  Mitelman+2  Mitelman (ISB-CGC) Chronic myelomonocytic leukemia  
  Mitelman-2  Mitelman (ISB-CGC) Diffuse large B-cell lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Diffuse large B-cell lymphoma  
  Mitelman-2  Mitelman (ISB-CGC) Extranodal NK/T-cell lymphoma  
  Mitelman-2  Mitelman (ISB-CGC)EyeMalignant melanoma  
  Mitelman+2  Mitelman (ISB-CGC)EyeMalignant melanoma  
  Mitelman-2  Mitelman (ISB-CGC)EyeRetinoblastoma  
  Mitelman+2  Mitelman (ISB-CGC)EyeRetinoblastoma  
  Mitelman-2  Mitelman (ISB-CGC) Follicular lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Follicular lymphoma[PubMed] 
  Mitelman-2  Mitelman (ISB-CGC)Gallbladder/Biliary systemAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Gallbladder/Biliary systemAdenocarcinoma  
  Mitelman-2  Mitelman (ISB-CGC) Hairy cell leukemia  
  Mitelman+2  Mitelman (ISB-CGC) Hodgkin disease, lymphocyte depletion  
  Mitelman-2  Mitelman (ISB-CGC) Hodgkin disease, lymphocyte predominance  
  Mitelman+2  Mitelman (ISB-CGC) Hodgkin disease, lymphocyte predominance  
  Mitelman-2  Mitelman (ISB-CGC) Hodgkin disease, mixed cellularity  
  Mitelman+2  Mitelman (ISB-CGC) Hodgkin disease, mixed cellularity  
  Mitelman-2  Mitelman (ISB-CGC) Hodgkin disease, nodular sclerosis  
  Mitelman+2  Mitelman (ISB-CGC) Hodgkin disease, nodular sclerosis  
  Mitelman+2  Mitelman (ISB-CGC) Hodgkin disease, NOS  
  Mitelman+2  Mitelman (ISB-CGC) Idiopathic myelofibrosis  
  Mitelman+2  Mitelman (ISB-CGC)IntraabdominalAlveolar rhabdomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)IntraabdominalEmbryonal rhabdomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)IntraabdominalEwing sarcoma  
  Mitelman-2  Mitelman (ISB-CGC)IntraabdominalGastrointestinal stromal tumor  
  Mitelman-2  Mitelman (ISB-CGC)IntraabdominalLeiomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)IntraabdominalLiposarcoma, dedifferentiated  
  Mitelman-2  Mitelman (ISB-CGC)IntraabdominalLiposarcoma, pleomorphic  
  Mitelman-2  Mitelman (ISB-CGC)IntraabdominalMalignant peripheral nerve sheath tumor/Triton  
  Mitelman-2  Mitelman (ISB-CGC)IntraabdominalNeuroblastoma  
  Mitelman+2  Mitelman (ISB-CGC)IntraabdominalNeuroblastoma  
  Mitelman+2  Mitelman (ISB-CGC)IntraabdominalSoft tissue tumor, special type  
  Mitelman-2  Mitelman (ISB-CGC)IntrathoracalTeratoma (mature and immature)  
  Mitelman+2  Mitelman (ISB-CGC)IntrathoracalTeratoma (mature and immature)  
  Mitelman-2  Mitelman (ISB-CGC)KidneyAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)KidneyAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)KidneyBenign epithelial tumor, special type  
  Mitelman-2  Mitelman (ISB-CGC)KidneyMalignant epithelial tumor, special type  
  Mitelman+2  Mitelman (ISB-CGC)KidneyMalignant epithelial tumor, special type  
  Mitelman+2  Mitelman (ISB-CGC)KidneyMesoblastic nephroma  
  Mitelman-2  Mitelman (ISB-CGC)KidneyOncocytoma  
  Mitelman+2  Mitelman (ISB-CGC)KidneySoft tissue tumor, special type  
  Mitelman-2  Mitelman (ISB-CGC)KidneyTransitional cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)KidneyWilms tumor  
  Mitelman+2  Mitelman (ISB-CGC)KidneyWilms tumor  
  Mitelman-2  Mitelman (ISB-CGC)Large intestineAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Large intestineAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Large intestineAdenoma  
  Mitelman-2  Mitelman (ISB-CGC)Large intestineCarcinoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)Large intestineCarcinoma, NOS  
  Mitelman-2  Mitelman (ISB-CGC)LarynxSquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)LarynxSquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)LiverAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)LiverHepatoblastoma  
  Mitelman-2  Mitelman (ISB-CGC)LungAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)LungAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)LungCarcinoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)LungMesenchymal tumor, special type  
  Mitelman-2  Mitelman (ISB-CGC)LungSquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)LungSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)LungUndifferentiated carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)LungUndifferentiated carcinoma, large cell  
  Mitelman+2  Mitelman (ISB-CGC)LungUndifferentiated carcinoma, large cell  
  Mitelman-2  Mitelman (ISB-CGC)LungUndifferentiated carcinoma, small cell  
  Mitelman+2  Mitelman (ISB-CGC)LungUndifferentiated carcinoma, small cell  
  Mitelman-2  Mitelman (ISB-CGC) Mantle cell lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Mantle cell lymphoma  
  Mitelman-2  Mitelman (ISB-CGC) Mastocytosis  
  Mitelman-2  Mitelman (ISB-CGC) Mature B-cell neoplasm, NOS  
  Mitelman+2  Mitelman (ISB-CGC) Mature B-cell neoplasm, NOS  
  Mitelman-2  Mitelman (ISB-CGC) Mature T- and NK-cell neoplasm, NOS  
  Mitelman+2  Mitelman (ISB-CGC) Mature T- and NK-cell neoplasm, NOS  
  Mitelman+2  Mitelman (ISB-CGC) Multiple myeloma  
  Mitelman-2  Mitelman (ISB-CGC) Multiple myeloma[PubMed] 
  Mitelman-2  Mitelman (ISB-CGC) Mycosis fungoides/Sézary syndrome  
  Mitelman-2  Mitelman (ISB-CGC) Myelodysplastic syndrome, NOS  
  Mitelman+2  Mitelman (ISB-CGC) Myelodysplastic syndrome, NOS  
  Mitelman+2  Mitelman (ISB-CGC)NasopharynxSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC) Nodal marginal zone B-cell lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Nodal marginal zone B-cell lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Nonneoplastic hematologic disorder/lesion  
  Mitelman-2  Mitelman (ISB-CGC)OesophagusAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)OesophagusAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)OesophagusSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)Oral cavitySquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Oral cavitySquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)Oro- and hypopharynxSquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Oro- and hypopharynxSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)OvaryAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)OvaryAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)OvaryAdenoma  
  Mitelman+2  Mitelman (ISB-CGC)OvaryCombined germ cell tumors  
  Mitelman-2  Mitelman (ISB-CGC)OvaryMalignant epithelial tumor, special type  
  Mitelman-2  Mitelman (ISB-CGC)PancreasAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)PancreasAdenocarcinoma  
  Mitelman-2  Mitelman (ISB-CGC)PancreasCarcinoid tumor  
  Mitelman-2  Mitelman (ISB-CGC) Peripheral T-cell lymphoma, unspecified  
  Mitelman+2  Mitelman (ISB-CGC) Peripheral T-cell lymphoma, unspecified  
  Mitelman-2  Mitelman (ISB-CGC) Plasma cell leukemia  
  Mitelman+2  Mitelman (ISB-CGC) Plasma cell leukemia  
  Mitelman-2  Mitelman (ISB-CGC)PleuraMesothelioma  
  Mitelman+2  Mitelman (ISB-CGC) Polycythemia vera  
  Mitelman-2  Mitelman (ISB-CGC) Primary effusion lymphoma  
  Mitelman+2  Mitelman (ISB-CGC) Primary effusion lymphoma  
  Mitelman-2  Mitelman (ISB-CGC)ProstateAdenocarcinoma  
  Mitelman-2  Mitelman (ISB-CGC) Refractory anemia  
  Mitelman+2  Mitelman (ISB-CGC) Refractory anemia  
  Mitelman+2  Mitelman (ISB-CGC) Refractory anemia with excess blasts-1  
  Mitelman-2  Mitelman (ISB-CGC) Refractory anemia with excess blasts-2  
  Mitelman-2  Mitelman (ISB-CGC) Refractory anemia with excess of blasts (FAB)  
  Mitelman+2  Mitelman (ISB-CGC) Refractory anemia with excess of blasts (FAB)  
  Mitelman+2  Mitelman (ISB-CGC) Refractory cytopenia with multilineage dysplasia  
  Mitelman+2  Mitelman (ISB-CGC)Salivary glandMucoepidermoid carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Salivary glandMyoepithelioma/myoepithelial carcinoma/mixed tumor  
  Mitelman+2  Mitelman (ISB-CGC)SkeletonChondrosarcoma, dedifferentiated  
  Mitelman-2  Mitelman (ISB-CGC)SkeletonChondrosarcoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)SkeletonChondrosarcoma, NOS  
  Mitelman-2  Mitelman (ISB-CGC)SkeletonChordoma  
  Mitelman+2  Mitelman (ISB-CGC)SkeletonChordoma  
  Mitelman-2  Mitelman (ISB-CGC)SkeletonEwing sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)SkeletonEwing sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)SkeletonFibrous dysplasia  
  Mitelman-2  Mitelman (ISB-CGC)SkeletonOsteosarcoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)SkeletonOsteosarcoma, NOS  
  Mitelman+2  Mitelman (ISB-CGC)SkinBasal cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)SkinMalignant melanoma  
  Mitelman+2  Mitelman (ISB-CGC)SkinMalignant melanoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueAlveolar rhabdomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueAlveolar rhabdomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueClear cell sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueClear cell sarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueDermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueDermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueEmbryonal rhabdomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueEmbryonal rhabdomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueEpithelioid sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueEpithelioid sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueEwing sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueFibrosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueLeiomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueLeiomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueLipoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueLiposarcoma, pleomorphic  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueMalignant peripheral nerve sheath tumor/Triton  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueMalignant peripheral nerve sheath tumor/Triton  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueMyxofibrosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueMyxoinflammatory fibroblastic sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueNonneoplastic mesenchymal disorder/lesion  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissuePleomorphic rhabdomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissuePleomorphic rhabdomyosarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueProliferative fasciitis/myositis  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueSolitary fibrous tumor  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueSuperficial fibromatosis  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueSynovial sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueSynovial sarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Soft tissueUndifferentiated pleomorphic sarcoma  
  Mitelman+2  Mitelman (ISB-CGC)Soft tissueUndifferentiated pleomorphic sarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Spinal cordEpendymoma  
  Mitelman+2  Mitelman (ISB-CGC)Spinal cordMeningioma  
  Mitelman-2  Mitelman (ISB-CGC) Splenic marginal zone B-cell lymphoma  
  Mitelman-2  Mitelman (ISB-CGC)StomachAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)StomachAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)StomachGastrointestinal stromal tumor  
  Mitelman-2  Mitelman (ISB-CGC)StomachLeiomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)TestisCombined germ cell tumors  
  Mitelman+2  Mitelman (ISB-CGC)TestisCombined germ cell tumors  
  Mitelman-2  Mitelman (ISB-CGC)TestisSeminoma/Dysgerminoma  
  Mitelman+2  Mitelman (ISB-CGC)TestisSeminoma/Dysgerminoma  
  Mitelman-2  Mitelman (ISB-CGC)TestisTeratoma (mature and immature)  
  Mitelman+2  Mitelman (ISB-CGC)TestisTeratoma (mature and immature)  
  Mitelman-2  Mitelman (ISB-CGC)ThyroidAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)ThyroidAdenocarcinoma  
  Mitelman-2  Mitelman (ISB-CGC)ThyroidAdenoma  
  Mitelman-2  Mitelman (ISB-CGC)ThyroidNonneoplastic epithelial disorder/lesion  
  Mitelman-2  Mitelman (ISB-CGC)TongueSquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)TongueSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC) T-prolymphocytic leukemia  
  Mitelman+2  Mitelman (ISB-CGC) T-prolymphocytic leukemia  
  Mitelman+2  Mitelman (ISB-CGC)Unknown siteEwing sarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Unknown siteMalignant melanoma  
  Mitelman+2  Mitelman (ISB-CGC)Unknown siteMalignant melanoma  
  Mitelman-2  Mitelman (ISB-CGC)Uterus, cervixSquamous cell carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Uterus, cervixSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC)Uterus, corpusAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Uterus, corpusAdenocarcinoma  
  Mitelman+2  Mitelman (ISB-CGC)Uterus, corpusEndometrial stromal sarcoma  
  Mitelman-2  Mitelman (ISB-CGC)Uterus, corpusLeiomyoma  
  Mitelman+2  Mitelman (ISB-CGC)Uterus, corpusMetaplastic carcinoma  
  Mitelman+2  Mitelman (ISB-CGC)VaginaEmbryonal rhabdomyosarcoma  
  Mitelman-2  Mitelman (ISB-CGC)VaginaSquamous cell carcinoma  
  Mitelman-2  Mitelman (ISB-CGC) Waldenström macroglobulinemia  
2 Atlas - Leukemia+2 or trisomy 2  Tri2ID1429MDS::AML[Biblio] 
[ Bold normal : A; Italic normal :G; Italic small : E ]

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
[previous]   2 2p 2q 2p25 2p24 2p23 2p22 2p21 2p16 2p15 2p14 2p13 2p12 2p11 2q11 2q12 2q13 2q14 2q21 2q22 2q23 2q24 2q31 2q32 2q33 2q34 2q35 2q36 2q37   [next]

References

Contributor(s)

Writtenmay 2012Philippe Dessen
  
Updatedjuin 2021Philippe Dessen and Jean-Loup Huret

Citation

This paper should be referenced as such :
Dessen P and Huret JL. Chromosomal band 2. Atlas Genet Cytogenet Oncol Haematol. July 2012.
URL : http://atlasgeneticsoncology.org/Bands/2.html
© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : sam. juin 5 15:02:39 CEST 2021


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching